Michael P. Kim is a Professor at The University of Texas MD Anderson Cancer Center, where he specializes in surgical oncology and pancreatic surgery. His research focuses on the molecular and clinical characterization of pancreatic adenocarcinoma, including KRAS mutation detection via liquid biopsy, multi-omics biomarker approaches for pancreatic cyst fluid risk stratification, and the metabolic vulnerabilities of IPMN-associated cancers. He has published in Nature, Gut, and JCO Precision Oncology, and his work on epithelial-to-mesenchymal transition and young-onset pancreatic cancer has advanced the understanding of tumor biology and metastasis. His research is supported by major grants, including a $729,000 award for investigating cooperative mechanisms of pancreatic cancer metastasis.
See moreHonors

Experiences

Education
